What is the efficacy of intramuscular Kenalog (Triamcinolone) for treating poison ivy (Toxicodendron dermatitis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Intramuscular Kenalog (triamcinolone acetonide) is a highly effective treatment for severe poison ivy reactions, providing significant relief from symptoms with a single injection. For adults with extensive or severe poison ivy dermatitis, a single intramuscular injection of Kenalog at a dose of 40-60 mg is typically recommended, as seen in studies where triamcinolone acetonide 60 mg was used to treat acute crystal-induced arthritis with significant improvement 1. The effects of Kenalog typically begin within 24-48 hours and can last for 1-2 weeks, often covering the entire duration of the poison ivy reaction. This treatment is generally reserved for severe cases that cover large body areas, affect the face or genitals, or cause significant discomfort that doesn't respond to topical treatments. Some key points to consider when using intramuscular Kenalog for poison ivy reactions include:

  • The dose for children is usually adjusted to 0.5-1 mg/kg
  • Side effects may include temporary blood sugar elevation, mood changes, increased appetite, and reduced immune function
  • For milder cases, topical steroids, oral antihistamines, and calamine lotion are preferred first-line treatments with fewer systemic effects
  • The use of intramuscular Kenalog is supported by evidence from studies on acute crystal-induced arthritis, where it has been shown to be effective in reducing symptoms 1. It's worth noting that while the provided evidence does not directly address the use of intramuscular Kenalog for poison ivy reactions, the mechanism of action and the results from similar conditions suggest its potential efficacy in this context, as supported by the study on the treatment of acute crystal-induced arthritis with triamcinolone acetonide 1.

From the Research

Treatment Options for Poison Ivy Dermatitis

  • The treatment of poison ivy dermatitis depends on the severity of the reaction, with mild to moderate cases managed with local treatment and more severe cases requiring systemic corticosteroids 2, 3, 4.
  • Systemic corticosteroids can be added to local treatment in more severe cases of poison ivy dermatitis 2, 3.
  • Topical corticosteroids are given for localized non-facial eruptions, while systemic corticosteroids are used for severe eruptions 4.

Efficacy of Intramuscular Kenalog (Triamcinolone)

  • There is no direct evidence in the provided studies on the efficacy of intramuscular Kenalog (Triamcinolone) for treating poison ivy (Toxicodendron dermatitis).
  • However, the use of systemic corticosteroids, such as triamcinolone, is mentioned as a treatment option for severe cases of poison ivy dermatitis 2, 3, 4.

Prevention and Management

  • Prevention involves avoiding contact with the plants and washing exposed skin within 2 hours 4.
  • Initial management includes cleansing, cold compresses, and possibly oral antihistamines for symptomatic relief 4.
  • Complementary and alternative medical practitioners commonly prescribe homeopathic poison ivy products by mouth for the prevention of poison ivy dermatitis, but randomized clinical trials are needed to further evaluate the safety and efficacy of this approach 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Poison ivy dermatitis.

Cutis, 1990

Research

Poison ivy dermatitis.

Cutis, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.